Suburban Propane Partners, L.P. (NYSE:SPH)(“Suburban Propane”), announced today the pricing of its offering of $350,000,000 aggregate principal amount of 6.500% senior notes due 2035 (the “2035 Senior Notes”) in a private placement not registered under the Securities Act of 1933, as amended (the “Securities Act”), at par. Suburban Energy Finance Corp., a wholly-owned direct subsidiary […]

NEW YORK CITY, NY / ACCESS Newswire / December 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Baidu, Inc. ("Baidu" or the "Company") (NASDAQ:BIDU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Baidu and certain of its officers and/or directors

(NASDAQ:SNPS), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired Synopsys securities between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon

BOSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today presented clinical data for CTD402, its investigational allogeneic anti-CD7 CAR-T cell therapy, in two oral sessions at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. The data underscore CTD402's potential to

SYNOPSYS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Synopsys, Inc. and Encourages Investors to Contact the Firm GlobeNewswire December 08, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss

Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting Two oral presentations showcase robust efficacy and durable responses GlobeNewswire December 08, 2025 BOSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today

(TSX-V:MFL),(Boerse Frankfurt – Freiverkehr:PM6),(TSX-V:FNM),(Nasdaq First North Sweden:FNMC-SDB.ST),(Other OTC:FNMCF),(Boerse Frankfurt – Freiverkehr:HEG0), VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mawson Finland Limited (“Mawson” or the “Company“) (TSX-V: MFL) is pleased to announce that the Ontario Superior Court of Justice (Commercial List) has granted the final order (the “Final Order“) in connection with the proposed

Vancouver, British Columbia–(Newsfile Corp. – December 8, 2025) – Resource Centrix Holdings Inc. (CSE: RECE) (“Resource Centrix” or the “Company“), that it has formally commenced the submission process for its application to dual-list to the OTCQB® Venture Market (the “OTCQB”) in the United States. The OTCQB® Venture Market is for entrepreneurial and development stage U.S.

Mawson Receives Final Order for Arrangement with First Nordic Metals GlobeNewswire December 08, 2025 VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Mawson Finland Limited (“Mawson” or the “Company“) (TSX-V: MFL) is pleased to announce that the Ontario Superior Court of Justice (Commercial List) has granted the final order (the “Final Order“) in connection

Lock-In 50% Off Any Membership for a Year for 1 Penny Today SAN ANTONIO, TEXAS / ACCESS Newswire / December 8, 2025 / Club Car Wash offers new guests its best deal to date leading up to its grand opening at 2815 SE Military Dr. For a limited time, the company is offering 50% off